<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE326nnn/GSE326195/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE326195</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Oxygen-generating microparticles enhance viability and functionality of human pluripotent stem cell-derived cardiomyocytes</name><description>Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) represent a promising therapy for myocardial infarction (MI), but their survival is severely limited by the hypoxic infarct environment. The optimal oxygen levels required to maintain the viability and functionality of hiPSC-CMs remain poorly defined. This study aimed to develop a controlled oxygen-delivery system to support engineered heart tissue (EHT) for cardiac regeneration. Oxygen-generating particles (OGPs) were engineered using peroxide (sodium percarbonate) and antioxidant (β-carotene) components encapsulated in PLGA microparticles. The effects of OGPs on hiPSC-CMs were evaluated through oxidative stress assays, cell viability analysis, and contractility measurements. RNA-seq was performed to investigate gene expression changes in hiPSC-CMs in response to OGPs and hypoxic stress. Transcriptomic analysis revealed that genes associated with CM maturation and contractile function were upregulated following OGP pretreatment. RNA-seq further demonstrated activation of oxygen-responsive metabolic pathways that facilitated cellular adaptation to hypoxic stress. OGP-mediated oxygen delivery offers a promising strategy for oxidative preconditioning and significantly improves the regenerative efficacy of hiPSC-CM-based cardiac therapies.</description><dates><publication>2026/04/01</publication></dates><accession>GSE326195</accession><cross_references><GSM>GSM9624879</GSM><GSM>GSM9624869</GSM><GSM>GSM9624877</GSM><GSM>GSM9624878</GSM><GSM>GSM9624882</GSM><GSM>GSM9624871</GSM><GSM>GSM9624872</GSM><GSM>GSM9624880</GSM><GSM>GSM9624881</GSM><GSM>GSM9624870</GSM><GSM>GSM9624875</GSM><GSM>GSM9624876</GSM><GSM>GSM9624873</GSM><GSM>GSM9624874</GSM><GPL>16791</GPL><GSE>326195</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>